Who owns BOLT BIOTHERAPEUTICS INC?
- Ticker: BOLT
- CUSIP Number: 097702104
Tip: Access positions for across all investors
Analyze quarterly positions in Bolt Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bolt Biotherapeutics stock
Who bought or sold BOLT BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Tang Capital Management | 3.7M | $4.1M | 3% | Dec 2023 |
|
| Vivo Capital | 3.5M | $4.9M | 0% | Mar 2024 |
|
| Citadel Advisors | 2.5M | $2.8M | -14% | Dec 2023 |
|
| Newtyn Management | 1.6M | $1.7M | 52% | Dec 2023 |
|
| OrbiMed Advisors | 1.5M | $1.7M | 0% | Dec 2023 |
|
| Samsara BioCapital | 1.0M | $1.2M | 0% | Dec 2023 |
|
| Vanguard Group | 931k | $1.0M | 1% | Dec 2023 |
|
| Board of Trustees of The Leland Stanford Junior University | 720k | $806k | -5% | Dec 2023 |
|
| Acuitas Investments | 460k | $515k | 0% | Dec 2023 |
|
| Marquette Asset Management | 97k | $108k | -1% | Dec 2023 |
|
| Squarepoint Ops | 80k | $89k | 0% | Dec 2023 |
|
| Two Sigma Securities | 64k | $72k | 100% | Dec 2023 |
|
| Jane Street | 56k | $63k | 100% | Dec 2023 |
|
| Millennium Management | 47k | $53k | 4% | Dec 2023 |
|
| UBS Group | 7.7k | $8.6k | 8797% | Dec 2023 |
|
| Advisor Group Holdings | 4.0k | $4.5k | 100% | Dec 2023 |
|
| Citigroup | 2.3k | $2.6k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 840.00 | $940.968000 | -99% | Dec 2023 |
|
| Bank of America Corporation | 628.00 | $702.983200 | 0% | Dec 2023 |
|
| Royal Bank of Canada | 465.00 | $0 | 395% | Dec 2023 |
|
| Wells Fargo & Company | 207.00 | $232.005600 | 5% | Dec 2023 |
|
| Barclays | 139.00 | $0 | 0% | Dec 2023 |
|
| Salem Investment Counselors | 40.00 | $56.000000 | 0% | Mar 2024 |
|
Who sold out of Bolt Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Federated Investors | Sep 2023 | 1.2k | $1.2k |